Family presence in the trauma bay is not entirely analogous to family presence during cardiopulmonary resuscitation (CPR) and requires a chaperone system.
AMA J Ethics. 2018;20(5):455-463. doi:
10.1001/journalofethics.2018.20.5.ecas5-1805.
Public and private choices about allocation of funds for research raise a social-justice question: are these funding sources making fair decisions about where to invest their resources? The NIH has the clearest obligation to do so because it is taxpayer-supported.
The question that comes to mind when one considers the risks of a clinical trial is, “Why would anyone agree to participate?” Interviews with trial volunteers and their family members make clear that often it is the appeal of discovering something new and unknown.
Clara C. Hildebrandt, MD and Jonathan M. Marron, MD, MPH
Gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies that could limit research participation by minority group members. These concerns can be addressed through public education, transparency, and stakeholder partnerships.
AMA J Ethics. 2018;20(9):E826-833. doi:
10.1001/amajethics.2018.826.
Giving undocumented immigrants and those with DACA status (DREAMers) access to health care and medical education enables them to contribute to these systems.
AMA J Ethics. 2017;19(3):221-233. doi:
10.1001/journalofethics.2017.19.3.peer1-1703.
Thoughtful design can welcome patients’ families’ roles in promoting healing. At the same time, clinicians’ need for functionality and privacy is critical. How ought these considerations be balanced in designing the spaces where patient care takes place?
AMA J Ethics. 2016;18(1):73-76. doi:
10.1001/journalofethics.2017.18.1.sect1-1601.